Bravo E L, Tarazi R C, Dustan H P
N Engl J Med. 1975 Jan 9;292(2):66-70. doi: 10.1056/NEJM197501092920203.
The influence of beta-adrenergic blockade (160 mg per day of propranolol for four weeks) on plasma renin activity, plasma volume, and arterial pressure was explored in 20 patients with essential hypertension with hyper-reninemia from long-term diuretic therapy. In 15 of these patients renin activity remained elevated (range, 3.1 to 23.0 ng per milliliter). Plasma volume was unchanged in eight, increased in 11 and reduced in one. In 17 subjects mean arterial pressure decreased by more than 10 mm Hg, but these impressive reductions could not be explained by quantitative changes in either renin activity (r equals 0.1) or plasma volume (r equals 0.1). These data suggest that suppression of plasma renin activity by beta-adrenergic blockade is not attainable during diuretic therapy and is not the major factor responsible for the antihypertensive action of propranolol.
对20例因长期利尿治疗导致高肾素血症的原发性高血压患者,探讨了β-肾上腺素能阻滞剂(每天160毫克普萘洛尔,持续四周)对血浆肾素活性、血浆容量和动脉压的影响。其中15例患者的肾素活性仍保持升高(范围为每毫升3.1至23.0纳克)。8例患者的血浆容量未变,11例增加,1例减少。17例受试者的平均动脉压下降超过10毫米汞柱,但这些显著的下降无法用肾素活性(r等于0.1)或血浆容量(r等于0.1)的定量变化来解释。这些数据表明,在利尿治疗期间,β-肾上腺素能阻滞剂无法抑制血浆肾素活性,且这不是普萘洛尔降压作用的主要因素。